James S Evans Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James S Evans.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James S Evans. James S Evans is Chief Financial Officer in MYRIAD GENETICS INC ($MYGN) and V.P. Finance in MYRIAD GENETICS INC ($MYGN) and Vice President Finance in MYRIAD GENETICS INC ($MYGN).
Latest Insider Trading Transactions of James S Evans
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 02 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 9.04 | 4,978 | 45,001 | 24,358 | |
| Oct 02 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.63 | 16,872 | 145,605 | 0 | |
| Oct 02 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 38.99 | 16,872 | 657,804 | 48,128 | 65 K to 48.1 K (-25.96 %) |
| Oct 02 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.63 | 16,872 | 145,605 | 65,000 | 48.1 K to 65 K (+35.06 %) |
| Oct 02 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 38.99 | 4,978 | 194,082 | 48,128 | 53.1 K to 48.1 K (-9.37 %) |
| Oct 02 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 9.04 | 4,978 | 45,001 | 53,106 | 48.1 K to 53.1 K (+10.34 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.12 | 75,864 | 2,285,024 | 8,790 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.12 | 3,000 | 90,360 | 84,654 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.12 | 2,346 | 70,662 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 23.11 | 4,328 | 100,020 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 16.53 | 1 | 17 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 13.28 | 5,324 | 70,703 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 12.17 | 5,808 | 70,683 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 9.04 | 664 | 6,003 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.63 | 13,128 | 113,295 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 38.08 | 75,864 | 2,889,098 | 48,128 | 124 K to 48.1 K (-61.18 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.12 | 75,864 | 2,285,024 | 123,992 | 48.1 K to 124 K (+157.63 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.98 | 3,000 | 113,940 | 48,128 | 51.1 K to 48.1 K (-5.87 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.12 | 3,000 | 90,360 | 51,128 | 48.1 K to 51.1 K (+6.23 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.51 | 13,128 | 492,431 | 48,128 | 61.3 K to 48.1 K (-21.43 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.63 | 13,128 | 113,295 | 61,256 | 48.1 K to 61.3 K (+27.28 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.51 | 664 | 24,907 | 48,128 | 48.8 K to 48.1 K (-1.36 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 9.04 | 664 | 6,003 | 48,792 | 48.1 K to 48.8 K (+1.38 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.34 | 5,808 | 216,853 | 48,128 | 53.9 K to 48.1 K (-10.77 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 12.17 | 5,808 | 70,683 | 53,936 | 48.1 K to 53.9 K (+12.07 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.34 | 5,324 | 198,782 | 48,128 | 53.5 K to 48.1 K (-9.96 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 13.28 | 5,324 | 70,703 | 53,452 | 48.1 K to 53.5 K (+11.06 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.51 | 2,346 | 87,998 | 48,128 | 50.5 K to 48.1 K (-4.65 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.12 | 2,346 | 70,662 | 50,474 | 48.1 K to 50.5 K (+4.87 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.34 | 4,328 | 161,595 | 48,128 | 52.5 K to 48.1 K (-8.25 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 23.11 | 4,328 | 100,020 | 52,456 | 48.1 K to 52.5 K (+8.99 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.34 | 1 | 37 | 48,128 | 48.1 K to 48.1 K (0.00 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 16.53 | 1 | 17 | 48,129 | 48.1 K to 48.1 K (0.00 %) |
| Sep 26 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.12 | 8,790 | 264,755 | 0 | |
| Sep 26 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.98 | 8,790 | 333,844 | 48,128 | 56.9 K to 48.1 K (-15.44 %) |
| Sep 26 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.12 | 8,790 | 264,755 | 56,918 | 48.1 K to 56.9 K (+18.26 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.34 | 76,139 | 2,310,057 | 0 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.34 | 3,861 | 117,143 | 0 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 40.00 | 3,861 | 154,440 | 47,609 | 51.5 K to 47.6 K (-7.50 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.34 | 3,861 | 117,143 | 51,470 | 47.6 K to 51.5 K (+8.11 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 40.00 | 76,139 | 3,045,560 | 47,609 | 123.7 K to 47.6 K (-61.53 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.34 | 76,139 | 2,310,057 | 123,748 | 47.6 K to 123.7 K (+159.93 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 7.27 | 30,000 | 218,100 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 36.01 | 30,000 | 1,080,375 | 47,609 | 77.6 K to 47.6 K (-38.66 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 7.27 | 30,000 | 218,100 | 77,609 | 47.6 K to 77.6 K (+63.01 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 7.82 | 26,250 | 205,275 | 0 | |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 7.82 | 8,750 | 68,425 | 26,250 | |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 33.04 | 26,250 | 867,363 | 47,609 | 73.9 K to 47.6 K (-35.54 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 7.82 | 26,250 | 205,275 | 73,859 | 47.6 K to 73.9 K (+55.14 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 33.04 | 8,750 | 289,121 | 47,609 | 56.4 K to 47.6 K (-15.53 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 7.82 | 8,750 | 68,425 | 56,359 | 47.6 K to 56.4 K (+18.38 %) |
| Nov 08 2013 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 6.00 | 8,072 | 48,432 | 0 | |
| Nov 08 2013 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.50 | 8,072 | 213,908 | 47,177 | 55.2 K to 47.2 K (-14.61 %) |
| Nov 08 2013 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 6.00 | 8,072 | 48,432 | 55,249 | 47.2 K to 55.2 K (+17.11 %) |
| Sep 19 2013 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 26.49 | 206,225 | 5,462,900 | 206,225 | |
| Sep 19 2013 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 26.49 | 3,775 | 100,000 | 3,775 | |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 5.89 | 3,792 | 22,335 | 0 | |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 5.89 | 30,630 | 180,411 | 3,792 | |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 5.89 | 578 | 3,404 | 0 | |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 28.06 | 3,792 | 106,414 | 46,771 | 50.6 K to 46.8 K (-7.50 %) |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 5.89 | 3,792 | 22,335 | 50,563 | 46.8 K to 50.6 K (+8.11 %) |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 28.06 | 30,630 | 859,561 | 46,771 | 77.4 K to 46.8 K (-39.57 %) |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 5.89 | 30,630 | 180,411 | 77,401 | 46.8 K to 77.4 K (+65.49 %) |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 28.06 | 578 | 16,220 | 46,771 | 47.3 K to 46.8 K (-1.22 %) |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 5.89 | 578 | 3,404 | 47,349 | 46.8 K to 47.3 K (+1.24 %) |
| Sep 28 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 4.44 | 26,250 | 116,550 | 0 | |
| Sep 28 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.99 | 26,250 | 708,396 | 46,771 | 73 K to 46.8 K (-35.95 %) |
| Sep 28 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 4.44 | 26,250 | 116,550 | 73,021 | 46.8 K to 73 K (+56.12 %) |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 27.07 | 190,000 | 5,143,300 | 190,000 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 3.80 | 5,494 | 20,877 | 0 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 27.10 | 5,494 | 148,887 | 46,771 | 52.3 K to 46.8 K (-10.51 %) |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 3.80 | 5,494 | 20,877 | 52,265 | 46.8 K to 52.3 K (+11.75 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 3.80 | 10,091 | 38,346 | 5,494 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 3.80 | 5,316 | 20,201 | 15,585 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 3.80 | 1,597 | 6,069 | 20,901 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 3.80 | 7,502 | 28,508 | 0 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 27.08 | 10,091 | 273,257 | 46,771 | 56.9 K to 46.8 K (-17.75 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 3.80 | 10,091 | 38,346 | 56,862 | 46.8 K to 56.9 K (+21.58 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.97 | 5,316 | 143,378 | 46,771 | 52.1 K to 46.8 K (-10.21 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 3.80 | 5,316 | 20,201 | 52,087 | 46.8 K to 52.1 K (+11.37 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.95 | 1,597 | 43,039 | 46,771 | 48.4 K to 46.8 K (-3.30 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 3.80 | 1,597 | 6,069 | 48,368 | 46.8 K to 48.4 K (+3.41 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.95 | 7,502 | 202,180 | 46,771 | 54.3 K to 46.8 K (-13.82 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 3.80 | 7,502 | 28,508 | 54,273 | 46.8 K to 54.3 K (+16.04 %) |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.68 | 340 | 2,951 | 0 | |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.68 | 15,056 | 130,686 | 340 | |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.68 | 4 | 35 | 0 | |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.01 | 4 | 104 | 46,771 | 46.8 K to 46.8 K (-0.01 %) |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.68 | 4 | 35 | 46,775 | 46.8 K to 46.8 K (+0.01 %) |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.01 | 340 | 8,845 | 46,771 | 47.1 K to 46.8 K (-0.72 %) |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.68 | 340 | 2,951 | 47,111 | 46.8 K to 47.1 K (+0.73 %) |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.01 | 15,056 | 391,656 | 46,771 | 61.8 K to 46.8 K (-24.35 %) |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.68 | 15,056 | 130,686 | 61,827 | 46.8 K to 61.8 K (+32.19 %) |
| Mar 16 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.68 | 4,600 | 39,928 | 15,396 | |
| Mar 16 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 25.01 | 4,600 | 115,026 | 45,598 | 50.2 K to 45.6 K (-9.16 %) |
| Mar 16 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.68 | 4,600 | 39,928 | 50,198 | 45.6 K to 50.2 K (+10.09 %) |
| Mar 08 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 23.98 | 33,830 | 811,243 | 33,830 | |
| Mar 08 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 23.98 | 4,170 | 99,997 | 4,170 | |
| Feb 07 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 12.64 | 6,400 | 80,896 | 0 | |
| Feb 07 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 12.64 | 2,200 | 27,808 | 6,400 | |
| Feb 07 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 12.64 | 198 | 2,503 | 8,600 | |
| Feb 07 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 12.64 | 2 | 25 | 0 | |
| Feb 07 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 23.98 | 6,400 | 153,472 | 45,598 | 52 K to 45.6 K (-12.31 %) |
| Feb 07 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 12.64 | 6,400 | 80,896 | 51,998 | 45.6 K to 52 K (+14.04 %) |
| Feb 07 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 23.98 | 2,200 | 52,756 | 45,598 | 47.8 K to 45.6 K (-4.60 %) |
| Feb 07 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 12.64 | 2,200 | 27,808 | 47,798 | 45.6 K to 47.8 K (+4.82 %) |
| Feb 07 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 24.00 | 2 | 48 | 45,598 | 45.6 K to 45.6 K (0.00 %) |
| Feb 07 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 12.64 | 2 | 25 | 45,600 | 45.6 K to 45.6 K (0.00 %) |
| Feb 07 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 24.00 | 198 | 4,752 | 45,598 | 45.8 K to 45.6 K (-0.43 %) |
| Feb 07 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 12.64 | 198 | 2,503 | 45,796 | 45.6 K to 45.8 K (+0.43 %) |
| Sep 15 2011 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 19.47 | 152,000 | 2,959,440 | 152,000 | |
| May 19 2011 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 23.53 | 5,000 | 117,650 | 0 | |
| May 19 2011 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 24.65 | 5,000 | 123,251 | 44,411 | 49.4 K to 44.4 K (-10.12 %) |
| May 19 2011 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 23.53 | 5,000 | 117,650 | 49,411 | 44.4 K to 49.4 K (+11.26 %) |
| May 16 2011 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 23.53 | 5,000 | 117,650 | 0 | |
| May 16 2011 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 23.53 | 5,000 | 117,650 | 5,000 | |
| May 16 2011 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 24.50 | 5,000 | 122,500 | 44,411 | 49.4 K to 44.4 K (-10.12 %) |
| May 16 2011 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 23.53 | 5,000 | 117,650 | 49,411 | 44.4 K to 49.4 K (+11.26 %) |
| Feb 24 2011 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 18.00 | 89,445 | 1,610,010 | 89,445 | |
| Feb 24 2011 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 18.00 | 5,555 | 99,990 | 5,555 | |
| Sep 17 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 16.53 | 84,999 | 1,405,033 | 84,999 | |
| Sep 17 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 16.53 | 1 | 17 | 1 | |
| May 10 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 4.44 | 8,750 | 38,850 | 0 | |
| May 10 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 4.44 | 8,750 | 38,850 | 43,041 | 34.3 K to 43 K (+25.52 %) |
| May 10 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 4.44 | 8,750 | 38,850 | 0 | |
| May 10 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 4.44 | 8,750 | 38,850 | 43,041 | 34.3 K to 43 K (+25.52 %) |
| Mar 12 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.86 | 1,680 | 14,885 | 0 | |
| Mar 12 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.86 | 6,720 | 59,539 | 0 | |
| Mar 12 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 24.15 | 6,720 | 162,288 | 34,291 | 41 K to 34.3 K (-16.39 %) |
| Mar 12 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.86 | 6,720 | 59,539 | 41,011 | 34.3 K to 41 K (+19.60 %) |
| Mar 12 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 23.15 | 1,680 | 38,892 | 34,291 | 36 K to 34.3 K (-4.67 %) |
| Mar 12 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.86 | 1,680 | 14,885 | 35,971 | 34.3 K to 36 K (+4.90 %) |
| Mar 05 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 23.11 | 75,672 | 1,748,780 | 75,672 | |
| Mar 05 2010 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 23.11 | 4,328 | 100,020 | 4,328 | |
| Sep 17 2009 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 30.34 | 76,139 | 2,310,057 | 76,139 | |
| Sep 17 2009 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 30.34 | 3,861 | 117,143 | 3,861 | |
| Feb 24 2009 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 5.56 | 7,920 | 44,055 | 0 | |
| Feb 24 2009 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 5.56 | 7,920 | 44,055 | 16,338 | 8.4 K to 16.3 K (+94.08 %) |
| Feb 20 2009 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 85.20 | 43,827 | 3,734,060 | 43,827 | |
| Feb 20 2009 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 85.20 | 1,173 | 99,940 | 1,173 | |
| Feb 05 2009 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 16.97 | 9,200 | 156,124 | 4,036 | |
| Feb 05 2009 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 16.97 | 1,764 | 29,935 | 13,236 | |
| Feb 05 2009 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 80.16 | 9,200 | 737,472 | 8,418 | 17.6 K to 8.4 K (-52.22 %) |
| Feb 05 2009 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 16.97 | 9,200 | 156,124 | 17,618 | 8.4 K to 17.6 K (+109.29 %) |
| Feb 05 2009 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 79.20 | 1,764 | 139,709 | 8,418 | 10.2 K to 8.4 K (-17.32 %) |
| Feb 05 2009 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 16.97 | 1,764 | 29,935 | 10,182 | 8.4 K to 10.2 K (+20.96 %) |
| Sep 29 2008 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 69.00 | 6,669 | 460,161 | 8,418 | 15.1 K to 8.4 K (-44.20 %) |
| Sep 12 2008 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 64.88 | 35,000 | 2,270,800 | 35,000 | |
| Feb 29 2008 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 37.56 | 27,338 | 1,026,815 | 27,338 | |
| Feb 29 2008 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 37.56 | 2,662 | 99,985 | 2,662 |